We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Researchers to Begin Testing New Male Contraceptive Injection in India
The item has been added to your shopping cart.
Researchers to Begin Testing New Male Contraceptive Injection in India
April 7, 2006
After a four-year delay, researchers in India have received regulatory approval to restart the trial of a male contraceptive, reversible inhibition of sperm under guidance (RISUG) — a nonhormonal treatment that provides 10 or more years of protection after a 10- to 15-minute outpatient procedure.